Conmed earnings were $73.4M for the trailing 12 months ending Sep 30, 2026, with 17.5% growth year over year. The latest CNMD earnings report on Sep 30, 2026 announced Q3 2026 earnings of $19.8M, down 14.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CNMD reported annual earnings of $47.1M, with -64.5% growth.
CNMD past earnings growth
How has CNMD's earnings growth performed historically?
On CNMD's earnings call on Oct 28, 2026, Conmed (NYSE: CNMD) reported Q3 2026 earnings per share (EPS) of $0.66, up 633.33% year over year. Total CNMD earnings for the quarter were $19.80 million. In the same quarter last year, Conmed's earnings per share (EPS) was $0.09.
As of the last Conmed earnings report, Conmed is currently profitable. Conmed's net profit (also called net income) for the twelve months ending Sep 30, 2026 was $73.43 million, a 14.61% increase year over year.
What was CNMD's earnings growth in the past year?
As of Conmed's earnings date in Oct 28, 2026, Conmed's earnings has grown 17.48% year over year. This is 24.58 percentage points higher than the US Medical Devices industry earnings growth rate of -7.1%. CNMD earnings in the past year totalled $73.43 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.